Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: A Bayesian cross-design meta-analysis

Catheterization and Cardiovascular Interventions

Volumn 86, Issue , 2015, Pages S15-S22

  Bittl, John A ^a   Tamis Holland, Jacqueline E ^b   Lang, Christopher D ^c   He, Yulei ^d  

^a Munroe Regional Med Center   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

myocardial infarction; percutaneous coronary intervention; randomized trials

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CULPRIT VESSEL INTERVENTION; HUMAN; META ANALYSIS; MORTALITY; MULTIVESSEL INTERVENTION; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; BAYES THEOREM; COMPLICATION; CORONARY BLOOD VESSEL; ELECTROCARDIOGRAPHY; HEART MUSCLE REVASCULARIZATION; MYOCARDIAL INFARCTION; PROCEDURES;

BAYES THEOREM; CORONARY ARTERY DISEASE; CORONARY VESSELS; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION;

EID: 84940957798     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26025     Document Type: Article

References (39)

1. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al., 2013 ACCF/AHA guideline for the management of ST-segment myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice Guidelines. Circulation 2013; 127: e1-e64. http://circ.ahajournals.org/content/early/2012/12/17/CIR.0b013e3182742cf6.
2. Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, et al., 2014 ESC/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2014; 35: 2541-2619.
3. Bangalore S, Kumar S, Poddar KL, Ramasamy S, Faxon S-WRDP,. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. Am J Cardiol 2011; 107: 1300-1310.
4. Vlaar PJ, Mahmoud KD, Holmes DR Jr, van Valkenhoef G, Hillege HL, van der Horst ICC, Zijlstra F, de Smet BJGL,. Culprit vessel only versus multivessel and staged coronary percutaneous coronary intervention for multivessel disease in patients presenting with ST-elevation myocardial infarction: A pairwise and network meta-analysis. J Am Coll Cardiol 2011; 58: 692-703.
5. Spiegelhalter DJ, Abrams KR, Myles JP., Bayesian Approaches to Clinical Trials and Health Care Evaluations. Chichester, England: Wiley; 2004.
6. Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P, Emanuela P, Stefano DS, Angelo R, Stefania C, et al., Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for acute myocardial infarction (HELP AMI) Study. Int J Cardiovasc Interv 2004; 6: 128-133.
7. Politi L, Sgura F, Rossi R, Monopoli D, Guerri E, Luezzi C, Bursi F, Sangiorgi GM, Modena MG,. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: Major adverse cardiac events during long-term follow-up. Heart 2010; 96: 662-667.
8. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, Berry C, Oldroyd KG,; for the PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-1123.
9. Gershlick A, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, et al., Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial. J Am Coll Cardiol 2015; 65: 963-972.
10. Roe MT, Cura FA, Joski PS, Garcia E, Guetta V, Kereiakes DJ, Zijlstra F, Brodie BR, Grines CL, Ellis SG,. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 2001; 88: 170-173.
11. Hannan EL, Samadashvili Z, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB III,. Culprit vessel percutaneous coronary intervention versus multivessel and staged coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. J Am Coll Cardiol Interv 2010; 3: 22-31.
12. Iqbal B, Ilsely C, Kabir T, Smith R, Lane R, Mason M, Archbold A, Clarke T, Firoozi S, Kalra S, et al., Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: Real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes 2014; 7: 936-943.
13. Corpus RA, House JA, Marso SP, Grantham JA, Huber KC Jr, Laster SB, Johnson WL, Daniels WC, Barth CW, Giorgi LV, et al., Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004; 148: 494-500.
14. Qarawani D, Nahir M, Abboud M, Hazanov Y, Hasin Y,. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 2008; 123: 288-292.
15. Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, Maresta A,. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc Interv 2008; 72: 927-933.
16. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS, Rao SV,. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the national cardiovascular data registry). Am J Cardiol 2009; 104: 507-513.
17. Dziewierz A, Siudak Z, Rakowski T, Zasad W, Dubiel JS, Dudek D,. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry). Am J Cardiol 2010; 106: 342-347.
18. Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes DR Jr, Hamm CW, Granger CB, Armstrong PW;, APEX-AMI Investigators. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: Insights from the APEX-AMI trial. Eur Heart J 2010; 31: 1701-1707.
19. Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK,. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: A analysis of over 4.400 patients in the EHS-PCI registry. Int J Cardiol 2013; 166: 596-600.
20. Jaguszewski M, Radavanovic D, Nallamothu BK, Lüscher TF, Urban P, Eberli FR, Bertel O, Pedrazzini GB, Windecker S, Jeger R, et al., Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: Is more worse? Eurointervention 2013; 9: 909-915.
21. Jeger R, Jaguszewski M, Nallamothu BK, Lüscher TF, Urban P, Pedrazzini GB, Erne P, Radavanovic D;, AMIS Plus Investigators. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: A Nationwide Study Cohort from the AMIS Plus Registry. Int J Cardiol 2014; 172: 76-81.
22. Santos AR, Piçarra BC, Celeiro M, Bento Â, Aguiar J, et al., Multivessel approach in ST-elevation myocardial infarction: Impact on in-hospital morbidity and mortality. Rev Port Cardiol 2014; 33: 67-73.
23. Manari A, Varani E, Guastaroba P, Menozzi A, Valgimigli M, Menozzi A, Magnavacchi P, Franco N, Marzocchi A, Casella G,. Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry. Catheter Cardiovasc Interv 2014; 84: 912-922.
24. He Y, Bittl JA, Wouhib A, Normand S-LT., Case study in cardiovascular medicine: Unprotected left main coronary artery disease. In:, Biondi-Zoccai G, editor. Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison. New York: Nova Science Publishers, Inc.; 2014; 285-306.
25. Lunn D, Jackson C, Best N, Thomas A, Spiegelhalter D., The BUGS Book: A Practical Introduction to Bayesian Analysis., Dominici F, Faraway JJ, Tanner M, Zidek J, editors. Boca Raton, FL: CRC Press; 2013; 219-22.
26. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
27. Lunn DJ, Thomas A, Best N, Spiegelhalter D,. WinBUGS-a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing, 2000; 10: 325-337.
28. Gelfand AE, Smith AFM,. Sampling-based approaches to calculate marginal densities. J Am Stat Assoc 1990; 85: 398-409.
29. Kruschke JK,. Doing Bayesian Data Analysis: A Tutorial with R and BUGS. Oxford, England: Elsevier; 2011.
30. Schwarzer G,. Package 'meta' version 3.8-0. Freiburg, Germany; 2012 For R: R Foundation for Statistical Computing, Vienna, Austria.
31. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr,. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009; 301: 831-841.
32. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, et al., ACCF/AHA/SCAI guidelines for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and Interventions. Circulation 2011; 124; e574-e565.
33. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Constantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, et al., Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716.
34. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW,. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
35. Davies MJ, Thomas A,. Thrombosis acute coronary-artery lesions in sudden ischemic cardiac death. N Engl J Med 1984; 310: 1137-1140.
36. Grines CL, Topol EJ, Califf RM, Stack RS, George BS, Kereiakes D, Boswick JM, Kline E, O'Neill WW,. Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. Circulation 2989; 80: 245-253.
37. Gibson CM, Ryan KA, Murphy SA, Mesley R, Marble SJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E,. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI study group. Thrombolysis in myocardial infarction. J Am Coll Cardiol 1999; 34: 974-982.
38. Hanratty CG, Koyamai Y, Rasmussen HH, Nelson GIC, Hansen PS, Ward MR,. Exaggeration of nonculprit stenosis during acute myocardial infarction: Implication for immediate multivessel revascularization. J Am Coll Cardiol 2002; 40: 911-916.
39. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assaki A, Classen B, Gersh BJ, Wong SC, Witzenbichler B, Guagliumi G, et al., Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: Analysis from the HORIZONS-AMI trial. J Am Coll Cardiol 2011; 58: 704-711.